Search Results

There are 12426 results for: content related to: Positive association of Phencyclidine-responsive genes, PDE4A and PLAT , with schizophrenia

  1. Proinflammatory cytokine regulation of cyclic AMP-phosphodiesterase 4 signaling in microglia in vitro and following CNS injury

    Glia

    Volume 60, Issue 12, December 2012, Pages: 1839–1859, Mousumi Ghosh, Daniela Garcia-Castillo, Vladimir Aguirre, Roozbeh Golshani, Coleen M. Atkins, Helen M. Bramlett, W. Dalton Dietrich and Damien D. Pearse

    Version of Record online : 2 AUG 2012, DOI: 10.1002/glia.22401

  2. You have free access to this content
    Dual PDE3/4 inhibitors as therapeutic agents for chronic obstructive pulmonary disease

    British Journal of Pharmacology

    Volume 157, Issue 6, July 2009, Pages: 892–906, Katharine H Banner and Neil J Press

    Version of Record online : 5 JUN 2009, DOI: 10.1111/j.1476-5381.2009.00170.x

  3. Differential expression and regulation of the cAMP-selective phosphodiesterase type 4A splice variants in rat brain by chronic antidepressant administration

    European Journal of Neuroscience

    Volume 22, Issue 6, September 2005, Pages: 1463–1475, Carrol D'Sa, Amelia J. Eisch, Graeme B. Bolger and Ronald S. Duman

    Version of Record online : 27 SEP 2005, DOI: 10.1111/j.1460-9568.2005.04321.x

  4. You have free access to this content
    Regulation of cAMP-specific phosphodiesterases type 4B and 4D (PDE4) splice variants by cAMP signaling in primary cortical neurons

    Journal of Neurochemistry

    Volume 81, Issue 4, May 2002, Pages: 745–757, Carrol D'Sa, Lara M. Tolbert, Marco Conti and Ronald S. Duman

    Version of Record online : 7 MAY 2002, DOI: 10.1046/j.1471-4159.2002.00878.x

  5. You have free access to this content
    Phosphodiesterase isoform-specific expression induced by traumatic brain injury

    Journal of Neurochemistry

    Volume 123, Issue 6, December 2012, Pages: 1019–1029, Anthony A. Oliva Jr., Yuan Kang, Concepcion Furones, Ofelia F. Alonso, Olga Bruno, W. Dalton Dietrich and Coleen M. Atkins

    Version of Record online : 1 NOV 2012, DOI: 10.1111/jnc.12049

  6. Enhanced long-term potentiation and impaired learning in phosphodiesterase 4D-knockout (PDE4D−/−) mice

    European Journal of Neuroscience

    Volume 28, Issue 3, August 2008, Pages: 625–632, Kris Rutten, Dinah L. Misner, Melissa Works, Arjan Blokland, Thomas J. Novak, Luca Santarelli and Tanya L. Wallace

    Version of Record online : 23 JUL 2008, DOI: 10.1111/j.1460-9568.2008.06349.x

  7. Development of Phosphodiesterase 4 Inhibitors for Allergic and Nonallergic Inflammatory Diseases of the Airways

    Standard Article

    Pharmaceutical Sciences Encyclopedia

    Mark A. Giembycz

    Published Online : 16 DEC 2011, DOI: 10.1002/9780470571224.pse471

  8. You have free access to this content
    Cyclic nucleotide phosphodiesterase (PDE) isozymes as targets of the intracellular signalling network: benefits of PDE inhibitors in various diseases and perspectives for future therapeutic developments

    British Journal of Pharmacology

    Volume 165, Issue 5, March 2012, Pages: 1288–1305, Thérèse Keravis and Claire Lugnier

    Version of Record online : 10 FEB 2012, DOI: 10.1111/j.1476-5381.2011.01729.x

  9. PDE4B as a microglia target to reduce neuroinflammation

    Glia

    Volume 64, Issue 10, October 2016, Pages: 1698–1709, Damien D. Pearse and Zoë A. Hughes

    Version of Record online : 1 APR 2016, DOI: 10.1002/glia.22986

  10. You have free access to this content
    Long PDE4 cAMP specific phosphodiesterases are activated by protein kinase A-mediated phosphorylation of a single serine residue in Upstream Conserved Region 1 (UCR1)

    British Journal of Pharmacology

    Volume 136, Issue 3, June 2002, Pages: 421–433, Simon J MacKenzie, George S Baillie, Ian McPhee, Carolynn MacKenzie, Rachael Seamons, Theresa McSorley, Jenni Millen, Matthew B Beard, Gino van Heeke and Miles D Houslay

    Version of Record online : 2 FEB 2009, DOI: 10.1038/sj.bjp.0704743

  11. The differential impact of PDE4 subtypes in human lung fibroblasts on cytokine-induced proliferation and myofibroblast conversion

    Journal of Cellular Physiology

    Volume 226, Issue 8, August 2011, Pages: 1970–1980, Jens Selige, Armin Hatzelmann and Torsten Dunkern

    Version of Record online : 25 APR 2011, DOI: 10.1002/jcp.22529

  12. You have free access to this content
    Remodelling of the PDE4 cAMP phosphodiesterase isoform profile upon monocyte-macrophage differentiation of human U937 cells

    British Journal of Pharmacology

    Volume 142, Issue 2, May 2004, Pages: 339–351, Malcolm C Shepherd, George S Baillie, David I Stirling and Miles D Houslay

    Version of Record online : 29 JAN 2009, DOI: 10.1038/sj.bjp.0705770

  13. Dysregulation of hepatic cAMP levels via altered Pde4b expression plays a critical role in alcohol-induced steatosis

    The Journal of Pathology

    Volume 240, Issue 1, September 2016, Pages: 96–107, Diana V Avila, David F Barker, JingWen Zhang, Craig J McClain, Shirish Barve and Leila Gobejishvili

    Version of Record online : 22 AUG 2016, DOI: 10.1002/path.4760

  14. You have free access to this content
    A new model of Pde4d deficiency: genetic knock-down of PDE4D enzyme in rats produces an antidepressant phenotype without spatial cognitive effects

    Genes, Brain and Behavior

    Volume 11, Issue 5, July 2012, Pages: 614–622, T. L. Schaefer, A. A. Braun, R. M. Amos-Kroohs, M. T. Williams, E. Ostertag and C. V. Vorhees

    Version of Record online : 8 MAY 2012, DOI: 10.1111/j.1601-183X.2012.00796.x

  15. You have free access to this content
    The MAP kinase ERK2 inhibits the cyclic AMP-specific phosphodiesterase HSPDE4D3 by phosphorylating it at Ser579

    The EMBO Journal

    Volume 18, Issue 4, February 15, 1999, Pages: 893–903, Ralf Hoffmann, George S. Baillie, Simon J. MacKenzie, Stephen J. Yarwood and Miles D. Houslay

    Version of Record online : 15 FEB 1999, DOI: 10.1093/emboj/18.4.893

  16. You have free access to this content
    Cyclic Nucleotide Phosphodiesterases: important signaling modulators and therapeutic targets

    Oral Diseases

    Volume 21, Issue 1, January 2015, Pages: e25–e50, F Ahmad, T Murata, K Shimizu, E Degerman, D Maurice and V Manganiello

    Version of Record online : 12 SEP 2014, DOI: 10.1111/odi.12275

  17. You have free access to this content
    Sub-family selective actions in the ability of Erk2 MAP kinase to phosphorylate and regulate the activity of PDE4 cyclic AMP-specific phosphodiesterases

    British Journal of Pharmacology

    Volume 131, Issue 4, October 2000, Pages: 811–819, George S Baillie, Simon J MacKenzie, Ian McPhee and Miles D Houslay

    Version of Record online : 29 JAN 2009, DOI: 10.1038/sj.bjp.0703636

  18. Temporal and spatial regulation of cAMP signaling in disease: role of cyclic nucleotide phosphodiesterases

    Fundamental & Clinical Pharmacology

    Volume 28, Issue 6, December 2014, Pages: 593–607, Carolina Otero, Juan P. Peñaloza, Paula I. Rodas, Ricardo Fernández-Ramires, Luis Velasquez and Juan E. Jung

    Version of Record online : 12 MAY 2014, DOI: 10.1111/fcp.12080

  19. You have free access to this content
    Suppression of human inflammatory cell function by subtype-selective PDE4 inhibitors correlates with inhibition of PDE4A and PDE4B

    British Journal of Pharmacology

    Volume 128, Issue 7, December 1999, Pages: 1393–1398, Carol D Manning, Miriam Burman, Siegfried B Christensen, Lenora B Cieslinski, David M Essayan, Marilyn Grous, Theodore J Torphy and Mary S Barnette

    Version of Record online : 30 JAN 2009, DOI: 10.1038/sj.bjp.0702911

  20. You have free access to this content
    PDE4 inhibitors: current status

    British Journal of Pharmacology

    Volume 155, Issue 3, October 2008, Pages: 308–315, D Spina

    Version of Record online : 29 JAN 2009, DOI: 10.1038/bjp.2008.307